Baker Bros. Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-299,969
Closed -$4.65M 102
2019
Q3
$4.65M Hold
299,969
0.03% 65
2019
Q2
$5.15M Hold
299,969
0.04% 63
2019
Q1
$4.83M Hold
299,969
0.03% 62
2018
Q4
$4.39M Sell
299,969
-150,000
-33% -$2.39M 0.04% 57
2018
Q3
$8.18M Sell
449,969
-833,960
-65% -$14.6M 0.05% 57
2018
Q2
$21.7M Sell
1,283,929
-297,495
-19% -$5.62M 0.16% 39
2018
Q1
$31M Hold
1,581,424
0.26% 32
2017
Q4
$32M Hold
1,581,424
0.28% 34
2017
Q3
$27.5M Hold
1,581,424
0.22% 28
2017
Q2
$20.3M Buy
1,581,424
+189,917
+14% +$2.54M 0.18% 30
2017
Q1
$18M Hold
1,391,507
0.15% 35
2016
Q4
$13.7M Sell
1,391,507
-339,550
-20% -$3.72M 0.13% 42
2016
Q3
$20.9M Sell
1,731,057
-107,000
-6% -$1.09M 0.19% 32
2016
Q2
$15.9M Sell
1,838,057
-93,000
-5% -$918K 0.17% 38
2016
Q1
$18.3M Hold
1,931,057
0.19% 37
2015
Q4
$33.5M Hold
1,931,057
0.28% 31
2015
Q3
$25.9M Hold
1,931,057
0.24% 31
2015
Q2
$43.6M Sell
1,931,057
-317,095
-14% -$5.57M 0.38% 28
2015
Q1
$32.1M Sell
2,248,152
-527,991
-19% -$7.61M 0.27% 33
2014
Q4
$26.8M Hold
2,776,143
0.27% 34
2014
Q3
$25.3M Hold
2,776,143
0.32% 31
2014
Q2
$27.4M Sell
2,776,143
-2,921,996
-51% -$24.8M 0.34% 34
2014
Q1
$72.4M Sell
5,698,139
-598,887
-10% -$8.89M 0.92% 18
2013
Q4
$94.4M Sell
6,297,026
-720,582
-10% -$9.27M 1.33% 14
2013
Q3
$77.5M Buy
7,017,608
+464,458
+7% +$3.87M 1.1% 14
2013
Q2
$52.1M Buy
+6,553,150
New +$41.7M 1.03% 15

Other funds holding HALO

Baker Bros. Advisors's HALO Position: Q4 2019 in Review

Baker Bros. Advisors sold out of Halozyme (HALO) in Q4 2019, closing a stake of 299,969 shares — an estimated $4.65M sold.

Baker Bros. Advisors first reported a position in HALO in Q2 2013 and held it in 26 quarters. The position peaked at $94.4M in Q4 2013. 224 funds tracked by Wall St. Rank hold HALO as of Q4 2019.

  • Baker Bros. Advisors reported no remaining Halozyme position as of Q4 2019 after selling out during the quarter.
  • Baker Bros. Advisors sold 299,969 Halozyme shares in Q4 2019, an estimated $4.65M.
  • Baker Bros. Advisors first reported a position in Halozyme in Q2 2013 and held it in 26 quarters.
  • Baker Bros. Advisors's Halozyme position peaked at $94.4M in Q4 2013.
  • 224 funds tracked by Wall St. Rank held Halozyme as of Q4 2019.

Based on Baker Bros. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.